SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (21)7/14/1998 12:31:00 PM
From: sam  Respond to of 1475
 
FWIW, some of the owners (actually, about 29% of the stock) include these limited partnerships:

HEALTHCARE VENTURES II LP 1,492,009
HEALTHCARE VENTURES III LP 774,834
HEALTHCARE VENTURES IV LP 228,504

H & Q seems to be very tied in, too. H & Q Capital Management, H & Q Life Science Investors and H & Q Healthcare Investors, combined, control (or controlled as of close of last year) close to 1,400,000 shares (or about 16% of the stock).

Short interest is negligible: 4,289 as of June.
What brokerage houses cover these guys?



To: Steve Lokness who wrote (21)7/14/1998 12:50:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1475
 
HealthCare Ventures, 30.8% of common outstanding!!

Rho Management, 8.7%, and an H&Q closed end fund, 8.6%. Then comes Novartis (6.2%) and Wisconsin (5.1%).

They're all hurting, of course. We need to be aware of anyone being squeezed, yes. But..... I'm really, really glad that their are dumbies out there.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News